Lifetime Cost-Effectiveness of Rosiglitazone/Metformin Fixed Dose Combination for the Treatment of Type 2 Diabetes in Portugal
AuthID
P-00F-KB7
P-00F-KB7
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service